|
Medazepam
|
DB13437 |
|
|
PF-06305591
|
DB12106 |
[Pf 06305591 is under investigation in clinical trial NCT01776619 (Safety and Tolerability Study of Multiple Doses of PF-06305591).] |
|
Pamiparib
|
DB14769 |
[Pamiparib is under investigation in clinical trial NCT03933761 (Pamiparib in Fusion Positive, Reversion Negative High Grade Serous Ovarian Cancer or Carcinosarcoma With BRCA1/2 Gene Mutations If Progression on Substrate Poly ADP Ribose Polymerase Inhibitbor (PARPI) or Chemotherapy).] |
|
PF-06459988
|
DB14768 |
[PF-06459988 is under investigation in clinical trial NCT02297425 (A Study For Patients With EGFRm (Epidermal Growth Factor Receptor Mutant) Lung Cancer).] |
|
Prolintane
|
DB13438 |
|
|
Vaborbactam
|
DB12107 |
[Vaborbactam is a β-lactamase inhibitor based on a cyclic boronic acid pharmacophore.[A32053] It has been used in trials investigating the treatment of bacterial infections in subjects with varying degrees of renal insufficiency. In August 2017, a combination antibacterial therapy under the market name Vabomere was approved by the FDA for the treatment of adult patients with complicated urinary tract infections (cUTI). Vabomere consists of vaborbactam and [Meropenem] for intravenous administration. Vaborbactam is added to the therapy to reduce the extent meropenem degradation by inhibiting the serine beta-lactamases expressed by the microorganism of target.[Label] The treatment aims to resolve infection-related symptoms of cUTI and achieve negative urine culture, when the infections are proven or strongly suspected to be caused by susceptible bacteria.] |
|
Fenpiprane
|
DB13439 |
|
|
Taselisib
|
DB12108 |
[Taselisib has been used in trials studying the treatment and basic science of LYMPHOMA, Breast Cancer, Ovarian Cancer, Solid Neoplasm, and HER2/Neu Negative, among others.] |
|
CPI-613
|
DB12109 |
[CPI-613 has been used in trials studying the treatment of Cancer, Lymphoma, Solid Tumors, Advanced Cancer, and Pancreatic Cancer, among others.] |
|
Simfibrate
|
DB13433 |
|
|
Fulranumab
|
DB12102 |
[Fulranumab has been used in trials studying the treatment of Pain, Cystitis, Neuralgia, Joint Pain, and Arthralgia, among others.] |
|
Rivoceranib
|
DB14765 |
[Rivoceranib is under investigation in clinical trial NCT02726854 (Apatinib as Second-line Treatment of Advanced Pancreatic Cancer).] |
|
Dengue tetravalent vaccine, live
|
DB14764 |
|
|
Fenticonazole
|
DB13434 |
|
|
Peginterferon lambda-1a
|
DB14767 |
[Peginterferon lambda-1a is under investigation in clinical trial NCT01754974 (Safety and Efficacy Study of Peginterferon Lambda-1a vs. Peginterferon Alfa-2a, Plus Ribavirin in Subjects With Genotype 1 Hepatitis C).] |
|
Tarextumab
|
DB12104 |
[Tarextumab has been used in trials studying the treatment of Solid Tumors, Stage IV Pancreatic Cancer, and Stage IV Small Cell Lung Cancer.] |
|
Endralazine
|
DB13435 |
|
|
Imagabalin
|
DB12105 |
[Imagabalin has been investigated in Generalized Anxiety Disorder.] |
|
Droxypropine
|
DB13436 |
|
|
Etrasimod
|
DB14766 |
[Etrasimod is under investigation in clinical trial NCT03945188 (Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis).] |
